Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Lemaitre Vascular (LMAT) Shares Outstanding (Weighted Average) (2016 - 2025)

Historic Shares Outstanding (Weighted Average) for Lemaitre Vascular (LMAT) over the last 10 years, with Q4 2024 value amounting to $22.5 million.

  • Lemaitre Vascular's Shares Outstanding (Weighted Average) rose 105.77% to $22.5 million in Q4 2024 from the same period last year, while for Dec 2024 it was $22.5 million, marking a year-over-year increase of 105.77%. This contributed to the annual value of $22.5 million for FY2024, which is 105.77% up from last year.
  • According to the latest figures from Q4 2024, Lemaitre Vascular's Shares Outstanding (Weighted Average) is $22.5 million, which was up 105.77% from $22.2 million recorded in Q4 2023.
  • Lemaitre Vascular's 5-year Shares Outstanding (Weighted Average) high stood at $22.5 million for Q4 2024, and its period low was $21.2 million during Q4 2021.
  • For the 4-year period, Lemaitre Vascular's Shares Outstanding (Weighted Average) averaged around $22.0 million, with its median value being $22.1 million (2022).
  • Its Shares Outstanding (Weighted Average) has fluctuated over the past 5 years, first soared by 386.63% in 2022, then soared by 105.77% in 2024.
  • Lemaitre Vascular's Shares Outstanding (Weighted Average) (Quarter) stood at $21.2 million in 2021, then grew by 3.87% to $22.0 million in 2022, then grew by 1.1% to $22.2 million in 2023, then grew by 1.06% to $22.5 million in 2024.
  • Its last three reported values are $22.5 million in Q4 2024, $22.2 million for Q4 2023, and $22.0 million during Q4 2022.